Headline
The latest stories from AHA Today.
The AHA urged the Centers for Medicare & Medicaid Services to extend the deadline for hospitals to submit 2020 data for the Medicare Promoting Interoperability Program from March 1 to at least May 1, 2021, citing problems this year with the system used to submit the data.
The Food and Drug Administration announced an import alert on all alcohol-based hand sanitizers from Mexico, noting that 84% of those it analyzed from April through December 2020 did not comply with FDA regulations and more than half contained toxic ingredients at dangerous levels, including…
The Department of Health and Human Services today will amend the Public Readiness and Emergency Preparedness Act to permit doctors and nurses who have recently retired or become inactive to administer COVID-19 vaccines and anyone currently licensed to vaccinate in their state to administer shots…
Ingrid Johnson, R.N., works with Atlantic Health System in Morristown, New Jersey, to raise awareness of human trafficking and how health care leaders can better identify victims and properly respond.
President Biden announced the federal government will purchase an additional 200 million doses of the two COVID-19 vaccines authorized by the Food and Drug Administration for emergency use.
Inspired by recent examples in sports and a Hamilton show tune, Kenneth Kaufman, managing director and chair of management consultancy KaufmanHall, challenges senior health care leaders to “make 2021 the year of true advancement in diversity, equity, and inclusion.”
The Joint Commission released for comment through Feb. 16 proposed new and revised workplace violence prevention standards for accredited hospitals and critical access hospitals.
The National Institutes of Health has launched an online data portal to collect clinical information on neurological symptoms, complications and outcomes related to COVID-19.
Drug maker Eli Lilly and Company said its neutralizing antibodies cocktail of bamlanivimab and etesevimab combine to significantly reduce hospitalizations and deaths attributed to COVID-19.
Regeneron Pharmaceuticals Inc. announced interim data indicating that its REGEN-COV antibody cocktail could be used as a passive vaccine to prevent COVID-19.